Urinary biomarkers in prostate cancer: to the miRnome and beyond
Transl Androl Urol
.
2020 Apr;9(2):843-845.
doi: 10.21037/tau.2019.11.25.
Authors
Christianne Hoey
1
2
3
,
Renu Jeyapala
4
5
,
Paul C Boutros
1
6
7
8
9
10
,
Bharati Bapat
4
5
11
12
,
Stanley K Liu
1
2
3
Affiliations
1
Department of Medical Biophysics, University of Toronto, Toronto, Canada.
2
Department of Radiation Oncology, University of Toronto, Toronto, Canada.
3
Sunnybrook-Odette Cancer Centre, Toronto, Canada.
4
Institute of Medical Science, University of Toronto, Toronto, Canada.
5
Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Canada.
6
Department of Human Genetics, University of California, Los Angeles, CA, USA.
7
Department of Urology, University of California, Los Angeles, CA, USA.
8
Broad Stem Cell Research Center, University of California, Los Angeles, CA, USA.
9
Institute for Precision Health, University of California, Los Angeles, CA, USA.
10
Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA, USA.
11
Department of Surgery and Surgical Oncology, Division of Urology, University Health Network, Toronto, Canada.
12
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
PMID:
32420197
PMCID:
PMC7214960
DOI:
10.21037/tau.2019.11.25
No abstract available
Publication types
Comment
Grants and funding
P30 CA016042/CA/NCI NIH HHS/United States
U01 CA214194/CA/NCI NIH HHS/United States